Deeks SG - Search Results

1

Virologic and immunologic response to HAART, by age and regimen class.

Althoff KN, Justice AC, Gange SJ, Deeks SG, Saag MS, Silverberg MJ, Gill MJ, Lau B, Napravnik S, Tedaldi E, Klein MB, Gebo KA; North American AIDS Cohorts Collaboration on Research, Design (NA-ACCORD). Althoff KN, et al. Among authors: deeks sg. AIDS. 2010 Oct 23;24(16):2469-79. doi: 10.1097/QAD.0b013e32833e6d14. AIDS. 2010. PMID: 20829678 Free PMC article.

2

Randomised trial of MNrgp120 HIV-1 vaccine in symptomless HIV-1 infection.

Eron JJ Jr, Ashby MA, Giordano MF, Chernow M, Reiter WM, Deeks SG, Lavelle JP, Conant MA, Yangco BG, Pate PG, Torres RA, Mitsuyasu RT, Twaddell T. Eron JJ Jr, et al. Among authors: deeks sg. Lancet. 1996 Dec 7;348(9041):1547-51. doi: 10.1016/s0140-6736(96)05283-x. Lancet. 1996. PMID: 8950881 Free article. Clinical Trial.

3

Activity of a ritonavir plus saquinavir-containing regimen in patients with virologic evidence of indinavir or ritonavir failure.

Deeks SG, Grant RM, Beatty GW, Horton C, Detmer J, Eastman S. Deeks SG, et al. AIDS. 1998 Jul 9;12(10):F97-102. doi: 10.1097/00002030-199810000-00002. AIDS. 1998. PMID: 9677159

4

HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy.

Deeks SG, Hecht FM, Swanson M, Elbeik T, Loftus R, Cohen PT, Grant RM. Deeks SG, et al. AIDS. 1999 Apr 16;13(6):F35-43. doi: 10.1097/00002030-199904160-00001. AIDS. 1999. PMID: 10397555

5

Sustained CD4+ T cell response after virologic failure of protease inhibitor-based regimens in patients with human immunodeficiency virus infection.

Deeks SG, Barbour JD, Martin JN, Swanson MS, Grant RM. Deeks SG, et al. J Infect Dis. 2000 Mar;181(3):946-53. doi: 10.1086/315334. J Infect Dis. 2000. PMID: 10720517

6

Reassessing the goal of antiretroviral therapy in the heavily pre-treated HIV-infected patient.

Deeks SG, Martin JN. Deeks SG, et al. AIDS. 2001 Jan 5;15(1):117-9. doi: 10.1097/00002030-200101050-00017. AIDS. 2001. PMID: 11192853 No abstract available.

7

Protease inhibitor-resistant HIV-1 from patients with preserved CD4 cell counts is cytopathic in activated CD4 T lymphocytes.

Liegler TJ, Hayden MS, Lee KH, Hoh R, Deeks SG, Granta RM. Liegler TJ, et al. Among authors: deeks sg. AIDS. 2001 Jan 26;15(2):179-84. doi: 10.1097/00002030-200101260-00006. AIDS. 2001. PMID: 11216925

8

Poor CD4 T cell restoration after suppression of HIV-1 replication may reflect lower thymic function.

Teixeira L, Valdez H, McCune JM, Koup RA, Badley AD, Hellerstein MK, Napolitano LA, Douek DC, Mbisa G, Deeks S, Harris JM, Barbour JD, Gross BH, Francis IR, Halvorsen R, Asaad R, Lederman MM. Teixeira L, et al. AIDS. 2001 Sep 28;15(14):1749-56. doi: 10.1097/00002030-200109280-00002. AIDS. 2001. PMID: 11579235

9

Duration and predictors of CD4 T-cell gains in patients who continue combination therapy despite detectable plasma viremia.

Deeks SG, Barbour JD, Grant RM, Martin JN. Deeks SG, et al. AIDS. 2002 Jan 25;16(2):201-7. doi: 10.1097/00002030-200201250-00009. AIDS. 2002. PMID: 11807304

10

Safety and antiviral activity at 48 weeks of lopinavir/ritonavir plus nevirapine and 2 nucleoside reverse-transcriptase inhibitors in human immunodeficiency virus type 1-infected protease inhibitor-experienced patients.

Benson CA, Deeks SG, Brun SC, Gulick RM, Eron JJ, Kessler HA, Murphy RL, Hicks C, King M, Wheeler D, Feinberg J, Stryker R, Sax PE, Riddler S, Thompson M, Real K, Hsu A, Kempf D, Japour AJ, Sun E. Benson CA, et al. Among authors: deeks sg. J Infect Dis. 2002 Mar 1;185(5):599-607. doi: 10.1086/339014. Epub 2002 Feb 14. J Infect Dis. 2002. PMID: 11865416 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

676 results

Search Page